Injectable Medication Sourcing Rules by State: A Clinic’s Guide

medication sourcing rules by state

Federal law sets the floor for compounded and injectable medication sourcing. Your state sets everything else — and the differences between states are bigger than most clinic owners expect. A sourcing arrangement that is routine in one state can require an extra license, an extra form, or a different supplier type one state over.

This guide explains the layers, gives you the exact questions to ask your state board, and lists every state board of pharmacy so you can verify in minutes.

Layer 1: The Federal Floor (Same in All 50 States)

These rules apply everywhere, before any state rule kicks in:

  • Patient-specific compounding runs through 503A pharmacies under state oversight. A valid prescription for a named patient is the federal condition.
  • Office-use stock (medication on the clinic shelf before a patient is identified) federally runs through FDA-registered 503B outsourcing facilities, which follow cGMP and are FDA-inspected. (Full explanation: see our 503A vs 503B Complete Guide.)
  • Compounded drugs are not FDA-approved — from either facility type, per FDA’s compounding laws page.
  • Controlled substances add a DEA layer on top of everything. Testosterone, for example, is Schedule III federally under the DEA’s Controlled Substances Act scheduling: the supplying pharmacy needs DEA registration, and prescribers need their own DEA registration. State controlled-substance schedules can be stricter than federal.
  • Bulk drug substances used in compounding must be on FDA’s 503A or 503B lists (or meet other statutory conditions). FDA maintains and updates these lists — worth checking for any specific compound your clinic is evaluating.

Layer 2: What Actually Varies by State

Nearly all state-level variation for clinic sourcing falls into five buckets:

1. Nonresident pharmacy licensure. When an out-of-state pharmacy ships into your state, your state almost certainly requires that pharmacy to hold a nonresident pharmacy license (sometimes “mail-order permit”) from your state board. This is the single most common compliance gap we see: a pharmacy that is perfectly licensed at home but not licensed to ship into the destination state.

2. Office-use and in-office administration rules. States differ on what clinics may keep as stock, in what quantities, and what records are required — and on whether any state-level allowances exist alongside the federal 503B pathway. This is the bucket with the most state-to-state spread.

3. Controlled-substance overlays. Some states schedule substances more strictly than the DEA does, require prescribers to register with a state monitoring program (PDMP), or add dispensing limits.

4. Who may order and receive. States define which license types (MD, DO, NP, PA — and their supervision requirements) may order injectables, hold stock, and administer. Scope-of-practice rules for NPs and PAs vary widely.

5. Wholesale distribution licensure. If a supplier is acting as a wholesaler/distributor rather than a pharmacy, it needs wholesale distribution licensure — in its home state and typically in yours.

The 5 Questions to Ask Before Sourcing Into Any State

Copy these into an email to your state board of pharmacy (or ask your sourcing coordinator to run the check):

  1. Does the supplying pharmacy hold a nonresident pharmacy license in this state? (Ask for license number; verify on the board’s lookup tool.)
  2. For clinic stock: is the supplier an FDA-registered 503B outsourcing facility, and does this state impose any additional registration on outsourcing facilities shipping in?
  3. Are there state-specific limits on office-use quantities, storage, or recordkeeping for injectables?
  4. Do any products involved fall under a stricter state controlled-substance schedule than federal?
  5. Are there practitioner-type restrictions on who may order, stock, or administer these medications in this state?

All 50 State Boards of Pharmacy (+ DC)

Every state’s rules are verifiable at the source. The National Association of Boards of Pharmacy maintains a directory of all member boards at nabp.pharmacy — the fastest route to any board’s website, license lookup, and contact form. FDA also publishes compounding information specifically for states, useful for understanding how federal and state oversight divide the work.

StateBoardNotes for clinic sourcing
AlabamaAlabama State Board of PharmacyPhoenix Meds Inc. home state. Confirm nonresident licensure of any out-of-state supplier with the board.
AlaskaAlaska Board of PharmacyConfirm with board.
ArizonaArizona State Board of PharmacyConfirm with board.
ArkansasArkansas State Board of PharmacyConfirm with board.
CaliforniaCalifornia State Board of PharmacyKnown for stricter-than-average requirements, including state licensure of outsourcing facilities shipping into CA. Verify current rules with the board.
ColoradoColorado State Board of PharmacyConfirm with board.
ConnecticutConnecticut Commission of PharmacyConfirm with board.
DelawareDelaware State Board of PharmacyConfirm with board.
District of ColumbiaDC Board of PharmacyConfirm with board.
FloridaFlorida Board of PharmacyHigh clinic/medspa density; nonresident pharmacy permits verifiable via state license lookup. Verify current rules with the board.
GeorgiaGeorgia State Board of PharmacyConfirm with board.
HawaiiHawaii State Board of PharmacyConfirm with board.
IdahoIdaho State Board of PharmacyConfirm with board.
IllinoisIllinois State Board of Pharmacy (IDFPR)Confirm with board.
IndianaIndiana Board of PharmacyConfirm with board.
IowaIowa Board of PharmacyConfirm with board.
KansasKansas State Board of PharmacyConfirm with board.
KentuckyKentucky Board of PharmacyConfirm with board.
LouisianaLouisiana Board of PharmacyConfirm with board.
MaineMaine Board of PharmacyConfirm with board.
MarylandMaryland Board of PharmacyConfirm with board.
MassachusettsMassachusetts Board of Registration in PharmacyPost-NECC, historically among the most active boards on compounding oversight. Verify current rules with the board.
MichiganMichigan Board of PharmacyConfirm with board.
MinnesotaMinnesota Board of PharmacyConfirm with board.
MississippiMississippi Board of PharmacyConfirm with board.
MissouriMissouri Board of PharmacyConfirm with board.
MontanaMontana Board of PharmacyConfirm with board.
NebraskaNebraska Board of PharmacyConfirm with board.
NevadaNevada State Board of PharmacyConfirm with board.
New HampshireNew Hampshire Board of PharmacyConfirm with board.
New JerseyNew Jersey Board of PharmacyConfirm with board.
New MexicoNew Mexico Board of PharmacyConfirm with board.
New YorkNew York State Board of Pharmacy (Office of the Professions)Verify current nonresident registration rules with the board.
North CarolinaNorth Carolina Board of PharmacyConfirm with board.
North DakotaNorth Dakota Board of PharmacyConfirm with board.
OhioOhio Board of PharmacyAlso licenses “terminal distributors of dangerous drugs” — clinics holding drug stock in OH typically need this license; verify categories with the board.
OklahomaOklahoma State Board of PharmacyConfirm with board.
OregonOregon Board of PharmacyConfirm with board.
PennsylvaniaPennsylvania State Board of PharmacyConfirm with board.
Rhode IslandRhode Island Board of PharmacyConfirm with board.
South CarolinaSouth Carolina Board of PharmacyConfirm with board.
South DakotaSouth Dakota State Board of PharmacyConfirm with board.
TennesseeTennessee Board of PharmacyConfirm with board.
TexasTexas State Board of PharmacyUses pharmacy license classes, including a nonresident class for out-of-state pharmacies shipping into TX. Verify current rules with the board.
UtahUtah Board of Pharmacy (DOPL)Confirm with board.
VermontVermont Board of PharmacyConfirm with board.
VirginiaVirginia Board of PharmacyConfirm with board.
WashingtonWashington Pharmacy Quality Assurance CommissionConfirm with board.
West VirginiaWest Virginia Board of PharmacyConfirm with board.
WisconsinWisconsin Pharmacy Examining BoardConfirm with board.
WyomingWyoming State Board of PharmacyConfirm with board.

“Confirm with board” means the board is your authoritative source for the five questions above — rules change, and this page will not always be ahead of your board’s latest bulletin. We re-review this page quarterly.

Why a Sourcing Coordinator Cares About All This

When a clinic in one state orders from a pharmacy in another, someone has to check the licensure match, the pathway (503A prescription vs. 503B stock), the controlled-substance overlay, and the practitioner authority — every time, for every combination. That verification burden is most of what a sourcing coordination platform exists to absorb — here’s how our coordination workflow handles it, and our shipping states page explains how partner licensure determines where medications can go. Whether you use ours or do it in-house, the checklist is the same; the only question is who runs it.

Frequently Asked Questions

Can an out-of-state pharmacy ship compounded medication to my clinic? Generally only if it holds a nonresident pharmacy license (or equivalent) issued by your state’s board. Verify the license number on your board’s lookup tool before the first order.

Is “office use” legal in my state? The reliable federal pathway for office stock is an FDA-registered 503B outsourcing facility. Whether your state adds requirements on top — or has any state-specific allowances — is a board-of-pharmacy question. Ask question 2 and 3 from the checklist above.

Do NPs and PAs face different sourcing rules than physicians? Often, yes — through scope-of-practice and supervision rules that vary by state. Check both your board of pharmacy and your professional licensing board.

Where do I check if a substance can be compounded at all? FDA’s Bulk Drug Substances Used in Compounding pages list substances under evaluation and their status for 503A and 503B use. Your supplier should be able to speak to the status of any compound they offer — it’s one of the vetting questions we walk through in our 503A vs 503B guide.

References

  1. FDA — Human Drug Compounding Laws
  2. FDA — Registered Outsourcing Facilities
  3. FDA — Bulk Drug Substances Used in Compounding
  4. FDA — Compounding Information for States
  5. NABP — Boards of Pharmacy directory
  6. DEA Diversion Control — Controlled Substances Act scheduling

Disclaimer:

Phoenix Meds Inc. is a healthcare supply coordination platform with 20+ years in pharmaceutical distribution. We coordinate sourcing between licensed clinics and licensed pharmacies; we are not a pharmacy, clinic, or law firm. We do not sell, dispense, or manufacture medications. This page is educational and is not legal advice; confirm requirements with your state boards.

Scroll to Top

Thank You!

Your order has been placed successfully.

Order Number #14327
Date May 19, 2025
Payment Method Credit Card (Stripe)
Please look out for an email from FedEx when your order ships.
Continue Shopping  ›